Latin American Cooperative Oncology Group

This study is testing whether some patients with early-stage, HER2-positive breast cancer can safely avoid chemotherapy before surgery. Researchers are using a specific biomarker test to select 63 participants whose cancer is highly dependent on the HER2 protein. These patients w…

This study is testing a new approach called 'extreme bipolar androgen therapy' for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. It alternates high doses of testosterone with a drug that blocks testosterone's effects, aim…

This study is testing a combination of three drugs (amivantamab, lazertinib, and pemetrexed) as the first treatment for people with advanced non-small cell lung cancer that has spread and has specific genetic changes (EGFR mutations). The goal is to see if this powerful combinati…

This study aimed to see if race affects how well a standard prostate cancer drug combination works for men with specific genetic changes in their tumors. It planned to enroll Black, Hispanic, White, and Native American men with advanced prostate cancer that had stopped responding…